<DOC>
	<DOCNO>NCT00367432</DOCNO>
	<brief_summary>This study plan evaluate safety efficacy L059 ( levetiracetam ) long-term administration patient complete N01020 [ NCT00160165 ] N01221 [ NCT00280696 ] .</brief_summary>
	<brief_title>A Long Term Follow Administration Study L059 ( Levetiracetam ) Epilepsy Patients With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Patients participate study N01221 [ NCT00280696 ] complete evaluation period transition period patient participate study N01020 [ NCT00160615 ] Female patient pregnancy , delivery lactation , suspect pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Epilepsies</keyword>
	<keyword>Partial</keyword>
	<keyword>Keppra</keyword>
	<keyword>levetiracetam</keyword>
</DOC>